Jérôme Martinez

Jérôme Martinez currently works at MDoloris Medical Systems SAS, as Chairman from 2025, Theranexus SA, as Independent Director from 2018, ErVimmune SA, as Director from 2021, and EarlySight SA, as Director.
Dr. Martinez also formerly worked at Novagali Pharma SA, as President & Chief Executive Officer from 2009 to 2011, BMI SYSTEM SAS, as Chairman, President & Chief Executive Officer from 2017 to 2019, Alliance Santé SA, as Deputy Director, Laboratoires Lavipharm, as Director-International Marketing, Alfred Fournier Institute, as Director, Lavipharm Corp., as Vice President-Marketing & Business Development, Ethypharm Corp., as Senior Vice President-Business Development, Roussel Uclaf Japan, as Head-Pharmaco Economic Project, and Santen Pharmaceutical Co., Ltd., as President-French Operations.
Dr. Martinez received his graduate degree in 1984 from Université de Paris XI Paris Sud, doctorate degree in 1983 from Université de Paris XI Paris Sud, Masters Business Admin degree in 1991 from École des Hautes Études Commerciales de Paris, and Masters Business Admin degree from Keio Business School.